Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 498 word(s) 498 2020-12-15 07:52:41

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Li, V. FANCA Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5509 (accessed on 23 June 2024).
Li V. FANCA Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5509. Accessed June 23, 2024.
Li, Vivi. "FANCA Gene" Encyclopedia, https://encyclopedia.pub/entry/5509 (accessed June 23, 2024).
Li, V. (2020, December 25). FANCA Gene. In Encyclopedia. https://encyclopedia.pub/entry/5509
Li, Vivi. "FANCA Gene." Encyclopedia. Web. 25 December, 2020.
FANCA Gene
Edit

FA complementation group A

genes

1. Normal Function

The FANCA gene provides instructions for making a protein that is involved in a cell process known as the Fanconi anemia (FA) pathway. The FA pathway is turned on (activated) when the process of making new copies of DNA, called DNA replication, is blocked due to DNA damage. The FA pathway is particularly responsive to a certain type of DNA damage known as interstrand cross-links (ICLs). ICLs occur when two DNA building blocks (nucleotides) on opposite strands of DNA are abnormally attached or linked together, which stops the process of DNA replication. ICLs can be caused by a buildup of toxic substances produced in the body or by treatment with certain cancer therapy drugs.

The FANCA protein is one of a group of proteins known as the FA core complex. The FA core complex is composed of eight FA proteins (including FANCA) and two proteins called Fanconi anemia-associated proteins (FAAPs). This complex activates two proteins, called FANCD2 and FANCI, by attaching a single molecule called ubiquitin to each of them (a process called monoubiquitination). The activation of these two proteins, which attach (bind) together to form the ID protein complex, attract DNA repair proteins to the area of DNA damage so the error can be corrected and DNA replication can continue.

2. Health Conditions Related to Genetic Changes

2.1 Fanconi Anemia

More than 450 mutations in the FANCA gene have been found to cause Fanconi anemia, a disorder characterized by a decrease in bone marrow function, an increased cancer risk, and physical abnormalities. Mutations in the FANCA gene are responsible for 60 to 70 percent of all cases of Fanconi anemia. These mutations change single DNA building blocks (nucleotides) or insert or delete pieces of DNA in the FANCA gene. Some mutations allow production of a FANCA protein that has some residual function; other mutations prevent the production of any FANCA protein. Mutations that prevent all protein production usually lead to a shortage of blood cells at an earlier age and increase the risk of developing cancer of the blood-forming cells (leukemia) as compared to mutations that allow for some FANCA protein production.

Mutations in the FANCA gene lead to a nonfunctional FA core complex, which disrupts the entire FA pathway. As a result, DNA damage is not repaired efficiently and ICLs build up over time. The ICLs stall DNA replication, ultimately resulting in either abnormal cell death due to an inability make new DNA molecules or uncontrolled cell growth due to a lack of DNA repair processes. Cells that divide quickly, such as bone marrow cells and cells of the developing fetus, are particularly affected. The death of these cells results in the decrease in blood cells and the physical abnormalities characteristic of Fanconi anemia. When the buildup of errors in DNA leads to uncontrolled cell growth, affected individuals can develop leukemia or other cancers.

3. Other Names for This Gene

  • FA

  • FAA

  • FACA

  • FANCA_HUMAN

  • Fanconi anemia complementation group A

  • Fanconi anemia, complementation group A

References

  1. de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia.Mutat Res. 2009 Jul 31;668(1-2):11-9. doi: 10.1016/j.mrfmmm.2008.11.004.
  2. Deakyne JS, Mazin AV. Fanconi anemia: at the crossroads of DNA repair.Biochemistry (Mosc). 2011 Jan;76(1):36-48. Review.
  3. Kee Y, D'Andrea AD. Expanded roles of the Fanconi anemia pathway in preservinggenomic stability. Genes Dev. 2010 Aug 15;24(16):1680-94. doi:10.1101/gad.1955310. Review.
  4. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recentprogress. Blood. 2006 Jun 1;107(11):4223-33.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 318
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020
1000/1000
Video Production Service